Category Archives: Hormone Replacement Therapy

Many women who used estrogen alone as hormone replacement therapy after menopause had a lower risk of developing breast cancer up to five years after they stopped taking it, a study has found. The research, published Tuesday, adds another twist to the evolving story on whether hormone replacement therapy helps some women beyond treating menopausal symptoms such as hot flashes and poor sleep quality. The report is a follow-up analysis of the landmark Women's Health Initiative, a clinical trial of tens of thousands of women begun in 1993 that sought to clarify the risks and benefits of two hormone replacement therapy regimens in postmenopausal women: estrogen plus progestin, which most women must take, and estrogen alone, taken by women who have had hysterectomies. The double-hormone arm of the study was abruptly halted in 2002 after scientists found that it raised the risk of breast cancer without conferring hoped-for benefits on the heart. In 2004, the estrogen-alone arm of the study was also halted after researchers discovered an increased risk of stroke and blood clots. At the time, it was not clear how estrogen alone affected breast cancer risk. But research since then found that estrogen alone did not increase risk … Continue reading →

TUESDAY, March 6 (HealthDay News) -- Some women who take estrogen-only hormone replacement therapy to stave off hot flashes, night sweats and other symptoms of menopause may be at lower risk for developing breast cancer down the road, a news study says. Hormone replacement therapy (HRT) fell from grace rather dramatically after a large government-run trial, the U.S. Women's Health Initiative, was stopped early in 2002 because HRT was shown to increase the risk of strokes and breast and ovarian cancer. Since that time, however, some subtleties have emerged as researchers parsed the evidence further. For example, short-term use of HRT is now deemed fairly safe for some women who have severe menopausal symptoms. The new study shows that longer-term use of estrogen-only therapy may actually lower a woman's odds of developing breast cancer. Estrogen-only therapy is reserved for women who have had a hysterectomy; women with an intact uterus who use HRT must take the hormone progestin with estrogen to prevent uterine cancer. "Women who have had a hysterectomy may be reassured that taking estrogen by itself, short term, to relieve menopausal symptoms will not increase their risk of breast cancer," said study author Garnet Anderson of the Women's … Continue reading →

While some forms of hormone replacement therapy have been found to increase breast cancer risk, therapies that use only estrogen may actually protect women against the disease, a new study says. Women in the study who took estrogen-only hormone replacement therapy (HRT) for six years were 23 percent less likely to develop breast cancer five years after they had stopped the therapy compared with women who never received HRT. Women who took estrogen-only HRT were also less likely to die of breast cancer. The findings mostly apply to women who have had a hysterectomy, as this is the group most likely to take estrogen-only HRT. The therapy raises the risk of uterine cancer, so the therapy is usually not prescribed for other women. "These latest results should provide reassurance about breast safety," for women taking estrogen for about five years after a hysterectomy for relief from postmenopausal symptoms, said study researcher Garnet Anderson, of the Fred Hutchinson Cancer Research Center in Seattle. However, the researchers said they do not recommend estrogen-only HRT as a way to reduce breast cancer risk in general. The lowered risk was not found in women with a family history of the disease, and the therapy … Continue reading →

PAULA GOODYER Can the contraceptive pill or Hormone Replacement Therapy (HRT) make it easier to gain weight? Some women say they do, but science isn't so sure. The jury's still out on whether the pill increases weight and a recent review of research into HRT and weight concluded there was no evidence that HRT added any more to the extra kilos that many women gain around menopause anyway. But research scientists Dr Vita Birzniece and Professor Ken Ho from Sydney's Garvan Institute of Medical Research have a different view. They believe that taking added oestrogen in pill form can make it harder for women to offload fat - a problem that starts when the hormone reaches the liver. "When women take oestrogen orally it goes directly to the liver where it interferes with the liver's ability to burn fat," Dr Birzniece explains. "Previous research here at the Garvan has shown that it's how women take this extra oestrogen that's important - when women take HRT in a patch form rather than a pill, the extra oestrogen bypasses the liver and doesn't affect fat burning - for this reason women are better off taking HRT in the form of a skin … Continue reading →

NEW YORK, Feb. 29, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 http://www.reportlinker.com/p0661223/Growth-Hormone-Deficiency-GHD-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, "Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Growth Hormone Deficiency (GHD) Therapeutics market. The report identifies the key trends shaping and driving the global Growth Hormone Deficiency (GHD) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Growth Hormone Deficiency (GHD) Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Scope The report provides information on the key drivers and challenges of the Growth Hormone Deficiency (GHD) Therapeutics market. Its scope includes … Continue reading →

SECAUCUS, N.J. and MIAMI, Feb. 22, 2012 /PRNewswire/ -- Panasonic Healthcare Group and CardioNexus Corporation announced today that they will outfit AAG Health & Wellness practices with the Panasonic CardioHealth Station. A leading Age Management and Hormone Replacement Therapy Center in the United States, AAG Health & Wellness will utilize the Panasonic CardioHealth Station, one of the latest ultrasound medical technologies, in their locations across the nation to support early heart disease detection and enhance their age management medicine programs. The Panasonic CardioHealth Station is designed to assist medical professionals in making a quick and valuable assessment of cardiovascular health and has been cleared by the FDA for use in the automated acquisition of carotid artery intima-media thickness to help ascertain cardiovascular risk. The Panasonic CardioHealth Station continues to gain the attention of preventive medical professionals, like AAG Health, who recognize that the best ways to reduce long-term healthcare costs is to apply cutting-edge technology to detect signs of disease at an early stage.  "AAG Health is proud to announce the acquisition of Panasonic's newest offering which provides our patients with the latest in diagnostic testing. AAG Health's Age Management, Healthy Aging and Hormone Treatment programs will incorporate the Panasonic CardioHealth Station as … Continue reading →

After losing 60 pounds in the fall of 2009, Dave Smith figured his energy level would improve. Related Content & Coverage ‘LOW T' SYMPTOMS Some men have a lower-than-normal testosterone level without signs or symptoms. For others, low testosterone may cause: - Changes in sexual function. This may include reduced sexual desire, fewer spontaneous erections - such as during sleep - and infertility. - Changes in sleep patterns. Sometimes low testosterone causes insomnia or other sleep disturbances. - Physical changes. Various physical changes are possible, including increased body fat, reduced muscle bulk and strength, and decreased bone density. Swollen or tender breasts and hair loss are possible. You may experience hot flashes and have less energy than you used to. - Emotional changes. Low testosterone may contribute to a decrease in motivation or self-confidence. You may feel sad or depressed, or have trouble concentrating or remembering things. It's important to note that some of these signs and symptoms are a normal part of aging. Others can be caused by various underlying factors, including medication side effects, thyroid problems, depression and excessive alcohol use. A blood test is the only way to diagnose a low testosterone level. Source: Mayo Clinic He … Continue reading →

DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/9c3351/medical_devices_an) has announced the addition of the "Medical Devices and Equipment Market in Iran" report to their offering. “Medical Devices and Equipment Market in Iran” Iran Medical Equipment: A comprehensive report on Iran's Medical Equipment & Hospital Supplies, suitable for the manufacturers and distributors who would like to enter and/or expand in the market. The report includes data and statistics on imported and locally manufactured equipment/products as well as information on how to participate in tenders and projects. The 5 major categories covered are: 1. Diagnostic imaging system 2. Artificial Internal Organ Apparatus & Clinical Equipment 3. Clinical test equipment (including measuring and monitoring system) 4. Therapeutic Equipment 5. Hospital Supplies Key Topics Covered: Introduction About the Report Product Categories under Investigation Country Overview Healthcare Policy and System Government Policy Briefing of Medical and Insurance System Public Private Overview of Medical Equipment Market Market Size and Forecast Import Trends Patterns of Best Selling Products Status of Foreign Companies/Products Tier1 Brands Others Main Projects/Plans Public Sector Private Sector Key Basic Information in Order to Penetrate into the Market Market Characteristics Distribution System Procurement Method Market Entry Method Main Events Trade Fairs and Their Effectiveness Other Tender Opportunities Import/Sales … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/2dd8e6/hormone_replacemen) has announced the addition of the "Hormone Replacement Therapy (HRT) - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The Report Profiles 42 Companies Including Many Key and Niche Players Such As: Bayer HealthCare Pharmaceuticals, Inc. Besins Healthcare SA Hisamitsu Pharmaceutical Co. Inc. Noven Pharmaceuticals Inc. Mylan Canada Novartis AG Novo Nordisk A/S Orion Corporation Pfizer Inc. Wyeth Pharmaceuticals Inc. Rottapharm SpA Teva Pharmaceutical Industries Ltd. Thramex Warner Chilcott Watson Pharmaceuticals Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources. Key Topics Covered: 1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 2. INDUSTRY OVERVIEW 3. MARKET TRENDS 4. PRODUCT OVERVIEW 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT KEY PLAYERS 7. GLOBAL MARKET PERSPECTIVE 8. THE UNITED STATES 9. CANADA 10. EUROPE 11. ASIA-PACIFIC 12. REST OF WORLD … Continue reading →

Wall Street Executives and soccer moms alike are visiting AntiAgingMedicine.md or TestosteroneReplacementTreatment.com and learning how Dr. Lionel Bissoon, D.O has helped thousands of his patients look & feel their best with testosterone replacement therapy. New York, NY (PRWEB) February 16, 2012 As people age, there are physical changes that take place in the body. These changes can be significant and life changing. For years, men and women had to suffer in silence from decline in testosterone, PMS, menopause and weight gain. However, hormone therapy has transformed millions of people’s lives. Dr. Lionel Bissoon a world-renowned expert on the use of hormone replacement therapy has discovered effective treatments for these hormone-related medical conditions and founded TestosteroneReplacementTreatment.com and AntiAgingMedicine.md so that people could learn more and improve their lives. Dr. Lionel Bissoon, a world-renowned expert on the use of hormone replacement therapy, has treated tens of thousands of men and women for decades. His peers highly praise him as a leader in Testosterone Replacement Treatment. He is a nationally recognized trailblazer for improving the lives of tens of thousands of men and women and a leading voice in the hormone therapy community. Dr. Bissoon recently featured in the prestigious Financial Times regarding … Continue reading →